FISTULIZING PERIANAL CROHN’S DISEASE: IS THE PATIENT’S SEX A BURDEN? A SYSTEMATIC REVIEW

ABSTRACT Background: Fistulizing perianal Crohn’s disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a worst outcome. Objective: Thus, the aim of this study was to assess whether sex influences the response to treatment for these pati...

Full description

Saved in:
Bibliographic Details
Published inArquivos de gastroenterologia Vol. 60; no. 4; pp. 490 - 524
Main Authors ROSEVICS, Leticia, SAVIO, Mariane Cristina, LIMA JÚNIOR, Emilton, RAMOS JÚNIOR, Odery
Format Journal Article
LanguageEnglish
Portuguese
Published Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE 01.11.2023
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
Subjects
Crohn’s disease
GASTROENTEROLOGY & HEPATOLOGY
perianal fistula
systematic review
treatment
treatment
revisão sistemática
fístula perianal
perianal fistula
Doença de Crohn
tratamento
systematic review
Crohn’s disease
Online AccessGet full text

Cover

Abstract ABSTRACT Background: Fistulizing perianal Crohn’s disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a worst outcome. Objective: Thus, the aim of this study was to assess whether sex influences the response to treatment for these patients. Methods: This systematic review (PROSPERO CRD42022319629) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. We selected articles published in English, Spanish, Portuguese, and Italian between 2010 and 2020 in the PubMed and Science Direct databases. According to the PICO acronym, prospective studies in patients older than 18 years with the objective of treating fistulizing perianal Crohn’s disease were selected. Studies in pediatric populations, retrospective, without treatment objectives, and that included only rectovaginal fistulas or a single sex were excluded. Study quality was assessed using the Cochrane risk of bias tool and Newcastle-Ottawa scale. Results: Of the 1887 articles found, 33 were included. Most studies used anti-TNF drugs as treatment (n=11). Ten studies had subgroup analyses; of them, the two studies reporting sex differences used infliximab and adalimumab as treatment and showed that women had a longer fistula closure time than men. Conclusion: This systematic review showed that few data corroborate the difference between sexes in the treatment of fistulizing perianal Crohn’s disease, possibly having a greater relationship with the phenotype. However, considering the lack of results, further studies with this objective and with standardization of fistulas and response assessment methods are needed. RESUMO Contexto: A doença de Crohn perianal fistulizante representa um desafio de tratamento, e postula-se que esse fenótipo em pacientes jovens do sexo masculino poderia ter um pior resultado. Objetivo: O objetivo deste estudo foi avaliar se o sexo influencia a resposta ao tratamento desses pacientes. Métodos: Esta revisão sistemática (PROSPERO CRD42022319629) foi conduzida de acordo com o protocolo Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Foram selecionados artigos publicados em inglês, espanhol, português e italiano entre 2010 e 2020 nas bases de dados PubMed e Science Direct. De acordo com o acrônimo PICO, foram selecionados estudos prospectivos em pacientes maiores de 18 anos com objetivo de tratamento da doença de Crohn perianal fistulizante. Foram excluídos estudos em populações pediátricas, retrospectivos, sem objetivos de tratamento e que incluíssem apenas fístulas retovaginais ou um único sexo. A qualidade dos estudos foi avaliada usando a ferramenta de risco de viés Cochrane e a escala Newcastle-Ottawa. Resultados: Dos 1.887 artigos encontrados, 33 foram incluídos. A maioria dos estudos utilizou medicamentos anti-TNF como tratamento (n=11). Dez estudos tiveram análises de subgrupos; deles, os dois estudos que relataram diferenças entre os sexos usaram infliximabe e adalimumabe como tratamento e mostraram que as mulheres tiveram um tempo de fechamento da fístula maior que os homens. Conclusão: Esta revisão sistemática mostrou que poucos dados corroboram a diferença entre os sexos no tratamento da doença de Crohn perianal fistulizante, possivelmente tendo maior relação com o fenótipo. Porém, dada à falta de resultados, são necessários mais estudos com esse objetivo e com padronização das fístulas e métodos de avaliação da resposta.
AbstractList ABSTRACT Background: Fistulizing perianal Crohn’s disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a worst outcome. Objective: Thus, the aim of this study was to assess whether sex influences the response to treatment for these patients. Methods: This systematic review (PROSPERO CRD42022319629) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. We selected articles published in English, Spanish, Portuguese, and Italian between 2010 and 2020 in the PubMed and Science Direct databases. According to the PICO acronym, prospective studies in patients older than 18 years with the objective of treating fistulizing perianal Crohn’s disease were selected. Studies in pediatric populations, retrospective, without treatment objectives, and that included only rectovaginal fistulas or a single sex were excluded. Study quality was assessed using the Cochrane risk of bias tool and Newcastle-Ottawa scale. Results: Of the 1887 articles found, 33 were included. Most studies used anti-TNF drugs as treatment (n=11). Ten studies had subgroup analyses; of them, the two studies reporting sex differences used infliximab and adalimumab as treatment and showed that women had a longer fistula closure time than men. Conclusion: This systematic review showed that few data corroborate the difference between sexes in the treatment of fistulizing perianal Crohn’s disease, possibly having a greater relationship with the phenotype. However, considering the lack of results, further studies with this objective and with standardization of fistulas and response assessment methods are needed. RESUMO Contexto: A doença de Crohn perianal fistulizante representa um desafio de tratamento, e postula-se que esse fenótipo em pacientes jovens do sexo masculino poderia ter um pior resultado. Objetivo: O objetivo deste estudo foi avaliar se o sexo influencia a resposta ao tratamento desses pacientes. Métodos: Esta revisão sistemática (PROSPERO CRD42022319629) foi conduzida de acordo com o protocolo Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Foram selecionados artigos publicados em inglês, espanhol, português e italiano entre 2010 e 2020 nas bases de dados PubMed e Science Direct. De acordo com o acrônimo PICO, foram selecionados estudos prospectivos em pacientes maiores de 18 anos com objetivo de tratamento da doença de Crohn perianal fistulizante. Foram excluídos estudos em populações pediátricas, retrospectivos, sem objetivos de tratamento e que incluíssem apenas fístulas retovaginais ou um único sexo. A qualidade dos estudos foi avaliada usando a ferramenta de risco de viés Cochrane e a escala Newcastle-Ottawa. Resultados: Dos 1.887 artigos encontrados, 33 foram incluídos. A maioria dos estudos utilizou medicamentos anti-TNF como tratamento (n=11). Dez estudos tiveram análises de subgrupos; deles, os dois estudos que relataram diferenças entre os sexos usaram infliximabe e adalimumabe como tratamento e mostraram que as mulheres tiveram um tempo de fechamento da fístula maior que os homens. Conclusão: Esta revisão sistemática mostrou que poucos dados corroboram a diferença entre os sexos no tratamento da doença de Crohn perianal fistulizante, possivelmente tendo maior relação com o fenótipo. Porém, dada à falta de resultados, são necessários mais estudos com esse objetivo e com padronização das fístulas e métodos de avaliação da resposta.
BACKGROUNDFistulizing perianal Crohn's disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a worst outcome.OBJECTIVEThus, the aim of this study was to assess whether sex influences the response to treatment for these patients.METHODSThis systematic review (PROSPERO CRD42022319629) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. We selected articles published in English, Spanish, Portuguese, and Italian between 2010 and 2020 in the PubMed and Science Direct databases. According to the PICO acronym, prospective studies in patients older than 18 years with the objective of treating fistulizing perianal Crohn's disease were selected. Studies in pediatric populations, retrospective, without treatment objectives, and that included only rectovaginal fistulas or a single sex were excluded. Study quality was assessed using the Cochrane risk of bias tool and Newcastle-Ottawa scale.RESULTSOf the 1887 articles found, 33 were included. Most studies used anti-TNF drugs as treatment (n=11). Ten studies had subgroup analyses; of them, the two studies reporting sex differences used infliximab and adalimumab as treatment and showed that women had a longer fistula closure time than men.CONCLUSIONThis systematic review showed that few data corroborate the difference between sexes in the treatment of fistulizing perianal Crohn's disease, possibly having a greater relationship with the phenotype. However, considering the lack of results, further studies with this objective and with standardization of fistulas and response assessment methods are needed.
ABSTRACT Background: Fistulizing perianal Crohn’s disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a worst outcome. Objective: Thus, the aim of this study was to assess whether sex influences the response to treatment for these patients. Methods: This systematic review (PROSPERO CRD42022319629) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. We selected articles published in English, Spanish, Portuguese, and Italian between 2010 and 2020 in the PubMed and Science Direct databases. According to the PICO acronym, prospective studies in patients older than 18 years with the objective of treating fistulizing perianal Crohn’s disease were selected. Studies in pediatric populations, retrospective, without treatment objectives, and that included only rectovaginal fistulas or a single sex were excluded. Study quality was assessed using the Cochrane risk of bias tool and Newcastle-Ottawa scale. Results: Of the 1887 articles found, 33 were included. Most studies used anti-TNF drugs as treatment (n=11). Ten studies had subgroup analyses; of them, the two studies reporting sex differences used infliximab and adalimumab as treatment and showed that women had a longer fistula closure time than men. Conclusion: This systematic review showed that few data corroborate the difference between sexes in the treatment of fistulizing perianal Crohn’s disease, possibly having a greater relationship with the phenotype. However, considering the lack of results, further studies with this objective and with standardization of fistulas and response assessment methods are needed.
Author ROSEVICS, Leticia
SAVIO, Mariane Cristina
RAMOS JÚNIOR, Odery
LIMA JÚNIOR, Emilton
AuthorAffiliation Universidade Federal do Paraná
Pontifícia Universidade Católica do Paraná
AuthorAffiliation_xml – name: Pontifícia Universidade Católica do Paraná
– name: Universidade Federal do Paraná
Author_xml – sequence: 1
  givenname: Leticia
  orcidid: 0000-0001-7307-1895
  surname: ROSEVICS
  fullname: ROSEVICS, Leticia
  organization: Universidade Federal do Paraná, Brasil
– sequence: 2
  givenname: Mariane Cristina
  orcidid: 0000-0002-7901-6093
  surname: SAVIO
  fullname: SAVIO, Mariane Cristina
  organization: Pontifícia Universidade Católica do Paraná, Brasil
– sequence: 3
  givenname: Emilton
  orcidid: 0000-0002-6887-9387
  surname: LIMA JÚNIOR
  fullname: LIMA JÚNIOR, Emilton
  organization: Universidade Federal do Paraná, Brasil
– sequence: 4
  givenname: Odery
  orcidid: 0000-0002-9730-6860
  surname: RAMOS JÚNIOR
  fullname: RAMOS JÚNIOR, Odery
  organization: Universidade Federal do Paraná, Brasil
BookMark eNo9UduO0zAUtNAi0S18A37kJcW32DEvKHS9W0slu6pTbkKyUsdBqbL1Em8feOM3-D2-BGeLKlnyGXvmnNGcS3BxCAcPwGuMFjiX6G1ECLGMFIguCEUMEURogs_ADHNRZIxgeQFmZ9ILcBnjHiHCpOQz8P1am3q71t90dQPv1EaXVbmGy83tqvr7-4-BV9qo0qh3UBtYrxS8K2utqvrpz6gvsIQftpsrVb1PlflqavUxEZZwoz5p9fkleN41Q_Sv_t9zsL1W9XKVrW9v9LJcZ46ivMgwKTxtiNs1udgxx4X33HW8pUj4wucdY0x6JITEopWetHzH24KwTkjOqBOEzoE-9W1Ds7cPY3_fjL9saHr79BDGH7YZH3s3eOta53LJO5ezgpFU0rboMPIU574VycccLE69ouv9EOw-HMdDMm_NFKGdIpwSnkA6EiXBm5PgYQw_jz4-2vs-Oj8MzcGHY0wKmRNOuMCJKk5UN4YYR9-dvWJkp2XaeB5iz8tMkP4DwwGKWA
Cites_doi 10.1111/apt.15665
10.1136/gut.21.6.525
10.1002/ibd.21405
10.1590/S0004-28032014000200004
10.1093/ecco-jcc/jjy019
10.1053/j.gastro.2017.04.001
10.1053/j.gastro.2019.05.067
10.1093/ecco-jcc/jjz187
10.1007/s00384-012-1581-9
10.1038/ajg.2011.60
10.1111/codi.14002
10.1093/ecco-jcc/jjy050
10.1136/gut.15.6.435
10.1007/s10151-017-1647-3
10.1002/stem.1357
10.1097/DCR.0b013e31825af532
10.1093/ecco-jcc/jjz180
10.1093/ecco-jcc/jjw169
10.1053/j.gastro.2021.04.022
10.1080/00365521.2020.1854848
10.1007/s10151-011-0759-4
10.1016/j.crohns.2010.12.012
10.1053/j.gastro.2019.01.032
10.1038/ajg.2008.38
10.1093/ibd/izz200
10.1016/j.crohns.2012.05.015
10.1111/j.1365-2036.2010.04509.x
10.1016/0140-6736(93)91375-V
10.1136/gutjnl-2013-304488
10.1053/j.gastro.2013.04.048
10.1177/1756284820915043
10.1136/gutjnl-2013-306709
10.1080/00325481.1981.11715884
10.3748/wjg.v24.i42.4821
10.1007/s10151-019-01932-z
10.1016/j.crohns.2010.07.012
10.1002/ibd.21663
10.1186/s13063-015-0831-x
10.1016/S0140-6736(15)00068-9
10.1155/2019/6132340
10.1097/MIB.0000000000000981
10.1016/S0140-6736(16)31203-X
10.1053/j.gastro.2010.02.013
10.1093/ecco-jcc/jjy113
10.1111/codi.12851
10.1016/j.dld.2011.07.021
10.1097/MIB.0000000000000031
10.1093/ecco-jcc/jjv162
10.1093/ecco-jcc/jjw168
10.1053/j.gastro.2015.06.014
10.1136/gut.17.3.192
10.1093/ecco-jcc/jjz119
10.1016/0016-5085(95)90277-5
10.1016/j.cgh.2018.01.030
10.1016/j.mayocp.2015.03.023
10.3727/096368912X656045
10.5009/gnl18157
10.1016/j.crohns.2012.01.002
10.1016/j.crohns.2011.06.002
10.1053/j.gastro.2019.02.005
10.1016/j.crohns.2011.08.015
ContentType Journal Article
Copyright This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright_xml – notice: This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
DBID AAYXX
CITATION
7X8
GPN
DOA
DOI 10.1590/s0004-2803.230402023-28
DatabaseName CrossRef
MEDLINE - Academic
SciELO
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Doença de Crohn perianal fistulizante: o gênero do paciente é relevante? Uma revisão sistemática
EISSN 1678-4219
EndPage 524
ExternalDocumentID oai_doaj_org_article_cdcc596fc54842c593d8f10e315ed78e
S0004_28032023000400490
10_1590_s0004_2803_230402023_28
GroupedDBID 23N
2WC
53G
5GY
5VS
6J9
AAYXX
ABXHO
ADBBV
ALMA_UNASSIGNED_HOLDINGS
APOWU
AZFZN
BAWUL
BCNDV
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
IPNFZ
KQ8
M~E
OK1
P2P
RIG
RNS
RSC
SCD
XSB
ZXP
7X8
GPN
ID FETCH-LOGICAL-c3058-128e3a2cba57b4c67ee6cf6d307e8e5f4449e077917d9e2d6b6d824f79643c723
IEDL.DBID DOA
ISSN 0004-2803
1678-4219
IngestDate Tue Oct 22 15:08:31 EDT 2024
Fri Oct 18 20:44:56 EDT 2024
Fri Jun 28 04:37:58 EDT 2024
Fri Aug 23 03:21:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords treatment
revisão sistemática
fístula perianal
perianal fistula
Doença de Crohn
tratamento
systematic review
Crohn’s disease
Language English
Portuguese
License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. http://creativecommons.org/licenses/by-nc/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3058-128e3a2cba57b4c67ee6cf6d307e8e5f4449e077917d9e2d6b6d824f79643c723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-9730-6860
0000-0002-7901-6093
0000-0002-6887-9387
0000-0001-7307-1895
OpenAccessLink https://doaj.org/article/cdcc596fc54842c593d8f10e315ed78e
PQID 2895262671
PQPubID 23479
PageCount 35
ParticipantIDs doaj_primary_oai_doaj_org_article_cdcc596fc54842c593d8f10e315ed78e
scielo_journals_S0004_28032023000400490
proquest_miscellaneous_2895262671
crossref_primary_10_1590_s0004_2803_230402023_28
PublicationCentury 2000
PublicationDate 20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 20231101
  day: 01
PublicationDecade 2020
PublicationTitle Arquivos de gastroenterologia
PublicationTitleAlternate Arq. Gastroenterol
PublicationYear 2023
Publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
Publisher_xml – name: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE
– name: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
References Lie MR (ref57) 2017; 23
Derkx B (ref59) 1993; 342
Cosnes J (ref22) 2013; 145
Farmer RG (ref42) 1981; 70
Khanna R (ref26) 2015
Romberg-Camps MJ (ref7) 2009; 104
Malian A (ref54) 2020; 26
Echarri A (ref9) 2010; 4
De Dombal FT (ref45) 1974; 15
Sciaudone G (ref12) 2010; 53
Reinisch W (ref24) 2014; 20
Maaser C (ref3) 2019; 13
Clerici M (ref15) 2011; 43
de la Poza G (ref46) 2012; 6
Mazor Y (ref6) 2011; 5
Brunner M (ref37) 2019; 23
f Gomollón (ref1) 2017; 11
Löwenberg M (ref38) 2019; 157
Law ST (ref55) 2014; 51
Adamina M (ref5) 2020; 14
Biemans VBC (ref40) 2020; 14
Cho YB (ref17) 2013; 22
Panaccione R (ref32) 2018; 12
Herreros MD (ref39) 2019; 2019
Haennig A (ref28) 2015; 17
Gecse KB (ref53) 2014; 63
Gionchetti P (ref2) 2017; 11
Panés J (ref29) 2016; 388
Panes J (ref64) 2018; 24
Dewint P (ref23) 2014; 63
Hellers G (ref44) 1980; 21
Zelinkova Z (ref61) 2012; 6
Billioud V (ref8) 2011; 106
Lee WY (ref19) 2013; 31
Löfberg R (ref16) 2012; 18
Molendijk I (ref25) 2015; 149
Alessandroni L (ref14) 2011; 15
Dietz AB (ref31) 2017; 153
Lee MJ (ref63) 2018; 16
Blumenstein I (ref56) 2011; 5
Feagan BG (ref33) 2018; 12
Chun J (ref47) 2018; 12
Schreiber S (ref11) 2011; 33
Torres J (ref4) 2020; 14
Truelove SC (ref43) 1976; 17
Serrero M (ref36) 2019; 156
Grimaud JC (ref10) 2010; 138
Tonelli F (ref18) 2012; 55
Dige A (ref35) 2019; 156
Wainstein C (ref34) 2018
de la Portilla F (ref20) 2013; 28
de Groof EJ (ref51) 2015; 16
van Dullemen HM (ref60) 1995; 109
Chapuis-Biron C (ref41) 2020; 51
Senéjoux A (ref30) 2016; 10
Feuerstein JD (ref52) 2021; 160
Attauabi M (ref62) 2021; 56
Braithwaite GC (ref48) 2017; 21
Melsheimer R (ref58) 2019; 13
Greuter T (ref49) 2020; 101
Schreiber S (ref21) 2013; 7
Roumeguère P (ref13) 2011; 17
Ciccocioppo R (ref27) 2015; 90
Rustgi SD (ref50) 2020; 13
Derkx, B; Taminiau, J; Radema, S; Stronkhorst, A; Wortel, C; Tytgat, G; van Deventer, S 1993; 342
Haennig, A; Staumont, G; Lepage, B; Faure, P; Alric, L; Buscail, L 2015; 17
Billioud, V; Sandborn, WJ; Peyrin-Biroulet, L 2011; 106
de la Portilla, F; Alba, F; García-Olmo, D; Herrerías, JM; González, FX; Galindo, A 2013; 28
Reinisch, W; Travis, S; Hanauer, S; Wang, H; Shara, N; Harris, MS 2014; 20
Roumeguère, P; Bouchard, D; Pigot, F; Castinel, A; Juguet, F; Gaye, D 2011; 17
de Groof, EJ; Buskens, CJ; Ponsioen, CY; Dijkgraaf, MG; D’Haens, GR; Srivastava, N 2015; 16
Dewint, P; Hansen, BE; Verhey, E; Oldenburg, B; Hommes, DW; Pierik, M 2014; 63
Dige, A; Hougaard, HT; Agnholt, J; Pedersen, BG; Tencerova, M; Kassem, M 2019; 156
Zelinkova, Z; Stokkers, PC; van der Linde, K; Kuipers, EJ; Peppelenbosch, MP; van der Woude, CP 2012; 6
Alessandroni, L; Kohn, A; Cosintino, R; Marrollo, M; Papi, C; Monterubbianesi, R; Tersigni, R 2011; 15
Khanna, R; Bressler, B; Levesque, BG; Zou, G; Stitt, LW; Greenberg, GR 2015
Biemans, VBC; van der Meulen-de Jong, AE; van der Woude, CJ; Löwenberg, M; Dijkstra, G; Oldenburg, B 2020; 14
f, Gomollón; a, dignass; v, annese; h, tilg; g, van; jo, lindsay 2017; 11
Wainstein, C; Quera, R; Fluxá, D; Kronberg, U; Conejero, A; López-Köstner, F 2018
van Dullemen, HM; van Deventer, SJ; Hommes, DW; Bijl, HA; Jansen, J; Tytgat, GN 1995; 109
Herreros, MD; Garcia-Olmo, D; Guadalajara, H; Georgiev-Hristov, T; Brandariz, L; Garcia-Arranz, M 2019; 2019
Romberg-Camps, MJ; Dagnelie, PC; Kester, AD; Hesselink-van de Kruijs, MA; Cilissen, M; Engels, LG 2009; 104
Echarri, A; Castro, J; Barreiro, M; Carpio, D; Pereira, S; Lorenzo, A 2010; 4
Maaser, C; Sturm, A; Vavricka, SR; Kucharzik, T; Fiorino, G; Annese, V 2019; 13
Dietz, AB; Dozois, EJ; Fletcher, JG; Butler, GW; Radel, D; Lightner, AL 2017; 153
Brunner, M; Schneider, I; Günther, K; Grützmann, R; Matzel, KE 2019; 23
Senéjoux, A; Siproudhis, L; Abramowitz, L; Munoz-Bongrand, N; Desseaux, K; Bouguen, G 2016; 10
Panes, J; Reinisch, W; Rupniewska, E; Khan, S; Forns, J; Khalid, JM 2018; 24
Serrero, M; Grimaud, F; Philandrianos, C; Visée, C; Sabatier, F; Grimaud, JC 2019; 156
Lie, MR; Kreijne, JE; van der Woude, CJ 2017; 23
Cosnes, J; Bourrier, A; Laharie, D; Nahon, S; Bouhnik, Y; Carbonnel, F 2013; 145
Melsheimer, R; Geldhof, A; Apaolaza, I; Schaible, T 2019; 13
Chun, J; Im, JP; Kim, JW; Lee, KL; Choi, CH; Kim, H 2018; 12
Schreiber, S; Lawrance, IC; Thomsen, OØ; Hanauer, SB; Bloomfield, R; Sandborn, WJ 2011; 33
Attauabi, M; Burisch, J; Seidelin, JB 2021; 56
Lee, MJ; Parker, CE; Taylor, SR; Guizzetti, L; Feagan, BG; Lobo, AJ 2018; 16
Feuerstein, JD; Ho, EY; Shmidt, E; Singh, H; Falck-Ytter, Y; Sultan, S 2021; 160
Lee, WY; Park, KJ; Cho, YB; Yoon, SN; Song, KH; Kim, DS 2013; 31
Löwenberg, M; Vermeire, S; Mostafavi, N; Hoentjen, F; Franchimont, D; Bossuyt, P 2019; 157
Panaccione, R; Sandborn, WJ; D’Haens, G; Wolf, DC; Berg, S; Maa, JF 2018; 12
de la Poza, G; López-Sanroman, A; Taxonera, C; Marín-Jimenez, I; Gisbert, JP; Bermejo, F 2012; 6
Schreiber, S; Reinisch, W; Colombel, JF; Sandborn, WJ; Hommes, DW; Robinson, AM 2013; 7
Farmer, RG 1981; 70
Tonelli, F; Giudici, F; Asteria, CR 2012; 55
Grimaud, JC; Munoz-Bongrand, N; Siproudhis, L; Abramowitz, L; Sénéjoux, A; Vitton, V 2010; 138
Malian, A; Rivière, P; Bouchard, D; Pigot, F; Eléouet-Kaplan, M; Favreau-Weltzer, C 2020; 26
Cho, YB; Lee, WY; Park, KJ; Kim, M; Yoo, HW; Yu, CS 2013; 22
Law, ST; Li, KK 2014; 51
Gionchetti, P; Dignass, A; Danese, S; Magro Dias, FJ; Rogler, G; Lakatos, PL 2017; 11
Sciaudone, G; Di Stazio, C; Limongelli, P; Guadagni, I; Pellino, G; Riegler, G 2010; 53
Torres, J; Bonovas, S; Doherty, G; Kucharzik, T; Gisbert, JP; Raine, T 2020; 14
Ciccocioppo, R; Gallia, A; Sgarella, A; Kruzliak, P; Gobbi, PG; Corazza, GR 2015; 90
Clerici, M; Cassinotti, A; Onida, F; Trabattoni, D; Annaloro, C; Della Volpe, A 2011; 43
Blumenstein, I; Herrmann, E; Filmann, N; Zosel, C; Tacke, W; Bock, H 2011; 5
Truelove, SC; Peña, AS 1976; 17
Mazor, Y; Maza, I; Kaufman, E; Ben-Horin, S; Karban, A; Chowers, Y; Eliakim, R 2011; 5
Gecse, KB; Bemelman, W; Kamm, MA; Stoker, J; Khanna, R; Ng, SC 2014; 63
Feagan, BG; Schwartz, D; Danese, S; Rubin, DT; Lissoos, TW; Xu, J; Lasch, K 2018; 12
Chapuis-Biron, C; Bourrier, A; Nachury, M; Nancey, S; Bouhnik, Y; Serrero, M 2020; 51
Panés, J; García-Olmo, D; Van Assche, G; Colombel, JF; Reinisch, W; Baumgart, DC 2016; 388
Adamina, M; Bonovas, S; Raine, T; Spinelli, A; Warusavitarne, J; Armuzzi, A 2020; 14
Hellers, G; Bergstrand, O; Rwerth, S; Holmström, B 1980; 21
Braithwaite, GC; Lee, MJ; Hind, D; Brown, SR 2017; 21
Löfberg, R; Louis, EV; Reinisch, W; Robinson, AM; Kron, M; Camez, A; Pollack, PF 2012; 18
Greuter, T; Manser, C; Pittet, V; Vavricka, SR; Biedermann, L 2020; 101
Rustgi, SD; Kayal, M; Shah, SC 2020; 13
Molendijk, I; Bonsing, BA; Roelofs, H; Peeters, KC; Wasser, MN; Dijkstra, G 2015; 149
De Dombal, FT; Burton, IL; Clamp, SE; Goligher, JC 1974; 15
References_xml – volume: 51
  start-page: 719
  year: 2020
  ident: ref41
  article-title: Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.15665
  contributor:
    fullname: Chapuis-Biron C
– volume: 21
  start-page: 525
  year: 1980
  ident: ref44
  article-title: Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease
  publication-title: Gut
  doi: 10.1136/gut.21.6.525
  contributor:
    fullname: Hellers G
– volume: 17
  start-page: 69
  year: 2011
  ident: ref13
  article-title: Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn’s disease: results from a prospective study
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21405
  contributor:
    fullname: Roumeguère P
– volume: 51
  start-page: 90
  year: 2014
  ident: ref55
  article-title: Gender-related differences in clinical course of crohns disease in an Asian population: a retrospective cohort review
  publication-title: Arq Gastroenterol
  doi: 10.1590/S0004-28032014000200004
  contributor:
    fullname: Law ST
– volume: 12
  start-page: 621
  year: 2018
  ident: ref33
  article-title: Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjy019
  contributor:
    fullname: Feagan BG
– volume: 153
  year: 2017
  ident: ref31
  article-title: Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2017.04.001
  contributor:
    fullname: Dietz AB
– volume: 157
  year: 2019
  ident: ref38
  article-title: Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.05.067
  contributor:
    fullname: Löwenberg M
– volume: 14
  start-page: 155
  year: 2020
  ident: ref5
  article-title: ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjz187
  contributor:
    fullname: Adamina M
– volume: 28
  start-page: 313
  year: 2013
  ident: ref20
  article-title: Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-012-1581-9
  contributor:
    fullname: de la Portilla F
– volume: 106
  start-page: 674
  year: 2011
  ident: ref8
  article-title: Loss of response and need for adalimumab dose intensification in Crohn’s disease: a systematic review
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2011.60
  contributor:
    fullname: Billioud V
– year: 2018
  ident: ref34
  article-title: Stem Cell Therapy in Refractory Perineal Crohn’s Disease: Long-term Follow-up
  publication-title: Colorectal Dis
  doi: 10.1111/codi.14002
  contributor:
    fullname: Wainstein C
– volume: 12
  start-page: 930
  year: 2018
  ident: ref32
  article-title: Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjy050
  contributor:
    fullname: Panaccione R
– volume: 15
  start-page: 435
  year: 1974
  ident: ref45
  article-title: Short-term course and prognosis of Crohn’s disease
  publication-title: Gut
  doi: 10.1136/gut.15.6.435
  contributor:
    fullname: De Dombal FT
– volume: 21
  start-page: 501
  year: 2017
  ident: ref48
  article-title: Prognostic factors affecting outcomes in fistulating perianal Crohn’s disease: a systematic review
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-017-1647-3
  contributor:
    fullname: Braithwaite GC
– volume: 31
  start-page: 2575
  year: 2013
  ident: ref19
  article-title: Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula
  publication-title: Stem Cells
  doi: 10.1002/stem.1357
  contributor:
    fullname: Lee WY
– volume: 55
  start-page: 870
  year: 2012
  ident: ref18
  article-title: Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn’s disease: a pilot study
  publication-title: Dis Colon Rectum
  doi: 10.1097/DCR.0b013e31825af532
  contributor:
    fullname: Tonelli F
– volume: 14
  start-page: 4
  year: 2020
  ident: ref4
  article-title: ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjz180
  contributor:
    fullname: Torres J
– volume: 11
  start-page: 135
  year: 2017
  ident: ref2
  article-title: 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjw169
  contributor:
    fullname: Gionchetti P
– volume: 160
  start-page: 2496
  year: 2021
  ident: ref52
  article-title: AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2021.04.022
  contributor:
    fullname: Feuerstein JD
– volume: 56
  start-page: 53
  year: 2021
  ident: ref62
  article-title: Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2020.1854848
  contributor:
    fullname: Attauabi M
– volume: 15
  start-page: 407
  year: 2011
  ident: ref14
  article-title: Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-011-0759-4
  contributor:
    fullname: Alessandroni L
– volume: 5
  start-page: 203
  year: 2011
  ident: ref56
  article-title: Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2010.12.012
  contributor:
    fullname: Blumenstein I
– volume: 156
  year: 2019
  ident: ref36
  article-title: Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.01.032
  contributor:
    fullname: Serrero M
– volume: 104
  start-page: 371
  year: 2009
  ident: ref7
  article-title: Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2008.38
  contributor:
    fullname: Romberg-Camps MJ
– volume: 26
  start-page: 926
  year: 2020
  ident: ref54
  article-title: Pedictors of Perianal Fistula Relapse in Crohn’s Disease
  publication-title: Inflamm Bowel Dis
  doi: 10.1093/ibd/izz200
  contributor:
    fullname: Malian A
– volume: 7
  start-page: 213
  year: 2013
  ident: ref21
  article-title: Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn’s disease
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2012.05.015
  contributor:
    fullname: Schreiber S
– volume: 33
  start-page: 185
  year: 2011
  ident: ref11
  article-title: Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2010.04509.x
  contributor:
    fullname: Schreiber S
– volume: 342
  start-page: 173
  year: 1993
  ident: ref59
  article-title: Tumour-necrosis-factor antibody treatment in Crohn’s disease
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)91375-V
  contributor:
    fullname: Derkx B
– volume: 63
  start-page: 292
  year: 2014
  ident: ref23
  article-title: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, double-blind, placebo controlled trial (ADAFI)
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-304488
  contributor:
    fullname: Dewint P
– volume: 145
  year: 2013
  ident: ref22
  article-title: Early administration of azathioprine vs conventional management of Crohn’s Disease: a randomized controlled trial
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2013.04.048
  contributor:
    fullname: Cosnes J
– volume: 13
  start-page: 1756284820915043
  year: 2020
  ident: ref50
  article-title: Sex-based differences in inflammatory bowel diseases: a review
  publication-title: Therap Adv Gastroenterol
  doi: 10.1177/1756284820915043
  contributor:
    fullname: Rustgi SD
– volume: 63
  start-page: 1381
  year: 2014
  ident: ref53
  article-title: A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-306709
  contributor:
    fullname: Gecse KB
– volume: 70
  start-page: 124
  year: 1981
  ident: ref42
  article-title: Long-term prognosis of inflammatory bowel disease
  publication-title: Postgrad Med
  doi: 10.1080/00325481.1981.11715884
  contributor:
    fullname: Farmer RG
– volume: 101
  start-page: 98
  year: 2020
  ident: ref49
  article-title: on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Gender Differences in Inflammatory Bowel Disease
  publication-title: Digestion
  contributor:
    fullname: Greuter T
– volume: 24
  start-page: 4821
  year: 2018
  ident: ref64
  article-title: Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i42.4821
  contributor:
    fullname: Panes J
– volume: 23
  start-page: 135
  year: 2019
  ident: ref37
  article-title: Permacol™ collagen paste for cryptoglandular and Crohn’s anal fistula
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-019-01932-z
  contributor:
    fullname: Brunner M
– volume: 4
  start-page: 654
  year: 2010
  ident: ref9
  article-title: Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn’s disease patients with infliximab failure
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2010.07.012
  contributor:
    fullname: Echarri A
– volume: 18
  start-page: 1
  year: 2012
  ident: ref16
  article-title: Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn’s disease: results from CARE
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21663
  contributor:
    fullname: Löfberg R
– volume: 16
  start-page: 366
  year: 2015
  ident: ref51
  article-title: Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
  publication-title: Trials
  doi: 10.1186/s13063-015-0831-x
  contributor:
    fullname: de Groof EJ
– start-page: 1825
  issue: 386
  year: 2015
  ident: ref26
  article-title: Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)00068-9
  contributor:
    fullname: Khanna R
– volume: 2019
  start-page: 6132340
  year: 2019
  ident: ref39
  article-title: Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula
  publication-title: Stem Cells Int
  doi: 10.1155/2019/6132340
  contributor:
    fullname: Herreros MD
– volume: 23
  start-page: 75
  year: 2017
  ident: ref57
  article-title: Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn’s Disease
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/MIB.0000000000000981
  contributor:
    fullname: Lie MR
– volume: 388
  start-page: 1281
  year: 2016
  ident: ref29
  article-title: Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31203-X
  contributor:
    fullname: Panés J
– volume: 138
  start-page: 2275
  year: 2010
  ident: ref10
  article-title: Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.02.013
  contributor:
    fullname: Grimaud JC
– volume: 13
  start-page: 144
  year: 2019
  ident: ref3
  article-title: ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjy113
  contributor:
    fullname: Maaser C
– volume: 17
  start-page: 311
  year: 2015
  ident: ref28
  article-title: The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn’s disease
  publication-title: Colorectal Dis
  doi: 10.1111/codi.12851
  contributor:
    fullname: Haennig A
– volume: 13
  start-page: 139
  year: 2019
  ident: ref58
  article-title: Remicade® (infliximab): 20 years of contributions to science and medicine
  publication-title: Biologics
  contributor:
    fullname: Melsheimer R
– volume: 43
  start-page: 946
  year: 2011
  ident: ref15
  article-title: Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn’s disease
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2011.07.021
  contributor:
    fullname: Clerici M
– volume: 20
  start-page: 872
  year: 2014
  ident: ref24
  article-title: AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn’s disease: FHAST-1, a phase 3, multicenter, placebo-controlled study
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/MIB.0000000000000031
  contributor:
    fullname: Reinisch W
– volume: 10
  start-page: 141
  year: 2016
  ident: ref30
  article-title: Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjv162
  contributor:
    fullname: Senéjoux A
– volume: 11
  start-page: 3
  year: 2017
  ident: ref1
  article-title: 3Rd european evidence-based consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjw168
  contributor:
    fullname: f Gomollón
– volume: 149
  year: 2015
  ident: ref25
  article-title: Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.06.014
  contributor:
    fullname: Molendijk I
– volume: 17
  start-page: 192
  year: 1976
  ident: ref43
  article-title: Course and prognosis of Crohn’s disease
  publication-title: Gut
  doi: 10.1136/gut.17.3.192
  contributor:
    fullname: Truelove SC
– volume: 14
  start-page: 33
  year: 2020
  ident: ref40
  article-title: Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjz119
  contributor:
    fullname: Biemans VBC
– volume: 109
  start-page: 129
  year: 1995
  ident: ref60
  article-title: Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(95)90277-5
  contributor:
    fullname: van Dullemen HM
– volume: 16
  start-page: 1879
  year: 2018
  ident: ref63
  article-title: Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2018.01.030
  contributor:
    fullname: Lee MJ
– volume: 90
  start-page: 747
  year: 2015
  ident: ref27
  article-title: Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2015.03.023
  contributor:
    fullname: Ciccocioppo R
– volume: 22
  start-page: 279
  year: 2013
  ident: ref17
  article-title: Autologous adipose tissue-derived stem cells for the treatment of Crohn’s fistula: a phase I clinical study
  publication-title: Cell Transplant
  doi: 10.3727/096368912X656045
  contributor:
    fullname: Cho YB
– volume: 53
  start-page: 299
  year: 2010
  ident: ref12
  article-title: Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach
  publication-title: Can J Surg
  contributor:
    fullname: Sciaudone G
– volume: 12
  start-page: 544
  year: 2018
  ident: ref47
  article-title: Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study
  publication-title: Gut Liver
  doi: 10.5009/gnl18157
  contributor:
    fullname: Chun J
– volume: 6
  start-page: 771
  year: 2012
  ident: ref61
  article-title: Maternal imprinting and female predominance in familial Crohn’s disease
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2012.01.002
  contributor:
    fullname: Zelinkova Z
– volume: 5
  start-page: 592
  year: 2011
  ident: ref6
  article-title: Prediction of disease complication occurrence in Crohn’s disease using phenotype and genotype parameters at diagnosis
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2011.06.002
  contributor:
    fullname: Mazor Y
– volume: 156
  year: 2019
  ident: ref35
  article-title: Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.02.005
  contributor:
    fullname: Dige A
– volume: 6
  start-page: 276
  year: 2012
  ident: ref46
  article-title: Genital fistulas in female Crohn’s disease patients.: clinical characteristics and response to therapy
  publication-title: J Crohns Colitis
  doi: 10.1016/j.crohns.2011.08.015
  contributor:
    fullname: de la Poza G
– volume: 21
  start-page: 525
  year: 1980
  end-page: 527
  article-title: Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease
  publication-title: Gut
  contributor:
    fullname: Hellers, G; Bergstrand, O; Rwerth, S; Holmström, B
– volume: 12
  start-page: 544
  year: 2018
  end-page: 554
  article-title: Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study
  publication-title: Gut Liver
  contributor:
    fullname: Chun, J; Im, JP; Kim, JW; Lee, KL; Choi, CH; Kim, H
– volume: 51
  start-page: 719
  year: 2020
  end-page: 727
  article-title: Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients
  publication-title: Aliment Pharmacol Ther
  contributor:
    fullname: Chapuis-Biron, C; Bourrier, A; Nachury, M; Nancey, S; Bouhnik, Y; Serrero, M
– volume: 15
  start-page: 407
  year: 2011
  end-page: 412
  article-title: Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study
  publication-title: Tech Coloproctol
  contributor:
    fullname: Alessandroni, L; Kohn, A; Cosintino, R; Marrollo, M; Papi, C; Monterubbianesi, R; Tersigni, R
– volume: 26
  start-page: 926
  year: 2020
  end-page: 931
  article-title: Pedictors of Perianal Fistula Relapse in Crohn’s Disease
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Malian, A; Rivière, P; Bouchard, D; Pigot, F; Eléouet-Kaplan, M; Favreau-Weltzer, C
– volume: 16
  start-page: 1879
  year: 2018
  end-page: 1892
  article-title: Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis
  publication-title: Clin Gastroenterol Hepatol
  contributor:
    fullname: Lee, MJ; Parker, CE; Taylor, SR; Guizzetti, L; Feagan, BG; Lobo, AJ
– volume: 17
  start-page: 69
  year: 2011
  end-page: 76
  article-title: Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn’s disease: results from a prospective study
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Roumeguère, P; Bouchard, D; Pigot, F; Castinel, A; Juguet, F; Gaye, D
– volume: 15
  start-page: 435
  year: 1974
  end-page: 443
  article-title: Short-term course and prognosis of Crohn’s disease
  publication-title: Gut
  contributor:
    fullname: De Dombal, FT; Burton, IL; Clamp, SE; Goligher, JC
– volume: 156
  year: 2019
  article-title: Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Dige, A; Hougaard, HT; Agnholt, J; Pedersen, BG; Tencerova, M; Kassem, M
– volume: 23
  start-page: 75
  year: 2017
  end-page: 81
  article-title: Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn’s Disease
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Lie, MR; Kreijne, JE; van der Woude, CJ
– volume: 17
  start-page: 311
  year: 2015
  end-page: 319
  article-title: The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn’s disease
  publication-title: Colorectal Dis
  contributor:
    fullname: Haennig, A; Staumont, G; Lepage, B; Faure, P; Alric, L; Buscail, L
– volume: 21
  start-page: 501
  year: 2017
  end-page: 519
  article-title: Prognostic factors affecting outcomes in fistulating perianal Crohn’s disease: a systematic review
  publication-title: Tech Coloproctol
  contributor:
    fullname: Braithwaite, GC; Lee, MJ; Hind, D; Brown, SR
– volume: 5
  start-page: 203
  year: 2011
  end-page: 210
  article-title: Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study
  publication-title: J Crohns Colitis
  contributor:
    fullname: Blumenstein, I; Herrmann, E; Filmann, N; Zosel, C; Tacke, W; Bock, H
– volume: 90
  start-page: 747
  year: 2015
  end-page: 755
  article-title: Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells
  publication-title: Mayo Clin Proc
  contributor:
    fullname: Ciccocioppo, R; Gallia, A; Sgarella, A; Kruzliak, P; Gobbi, PG; Corazza, GR
– volume: 20
  start-page: 872
  year: 2014
  end-page: 881
  article-title: AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn’s disease: FHAST-1, a phase 3, multicenter, placebo-controlled study
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Reinisch, W; Travis, S; Hanauer, S; Wang, H; Shara, N; Harris, MS
– volume: 11
  start-page: 135
  year: 2017
  end-page: 149
  article-title: 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
  publication-title: J Crohns Colitis
  contributor:
    fullname: Gionchetti, P; Dignass, A; Danese, S; Magro Dias, FJ; Rogler, G; Lakatos, PL
– volume: 106
  start-page: 674
  year: 2011
  end-page: 684
  article-title: Loss of response and need for adalimumab dose intensification in Crohn’s disease: a systematic review
  publication-title: Am J Gastroenterol
  contributor:
    fullname: Billioud, V; Sandborn, WJ; Peyrin-Biroulet, L
– volume: 55
  start-page: 870
  year: 2012
  end-page: 875
  article-title: Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn’s disease: a pilot study
  publication-title: Dis Colon Rectum
  contributor:
    fullname: Tonelli, F; Giudici, F; Asteria, CR
– volume: 7
  start-page: 213
  year: 2013
  end-page: 221
  article-title: Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn’s disease
  publication-title: J Crohns Colitis
  contributor:
    fullname: Schreiber, S; Reinisch, W; Colombel, JF; Sandborn, WJ; Hommes, DW; Robinson, AM
– volume: 4
  start-page: 654
  year: 2010
  end-page: 660
  article-title: Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn’s disease patients with infliximab failure
  publication-title: J Crohns Colitis
  contributor:
    fullname: Echarri, A; Castro, J; Barreiro, M; Carpio, D; Pereira, S; Lorenzo, A
– volume: 11
  start-page: 3
  year: 2017
  end-page: 25
  article-title: 3Rd european evidence-based consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
  publication-title: J Crohns Colitis
  contributor:
    fullname: f, Gomollón; a, dignass; v, annese; h, tilg; g, van; jo, lindsay
– volume: 63
  start-page: 292
  year: 2014
  end-page: 299
  article-title: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, double-blind, placebo controlled trial (ADAFI)
  publication-title: Gut
  contributor:
    fullname: Dewint, P; Hansen, BE; Verhey, E; Oldenburg, B; Hommes, DW; Pierik, M
– volume: 31
  start-page: 2575
  year: 2013
  end-page: 2581
  article-title: Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula
  publication-title: Stem Cells
  contributor:
    fullname: Lee, WY; Park, KJ; Cho, YB; Yoon, SN; Song, KH; Kim, DS
– volume: 17
  start-page: 192
  year: 1976
  end-page: 201
  article-title: Course and prognosis of Crohn’s disease
  publication-title: Gut
  contributor:
    fullname: Truelove, SC; Peña, AS
– volume: 156
  year: 2019
  article-title: Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Serrero, M; Grimaud, F; Philandrianos, C; Visée, C; Sabatier, F; Grimaud, JC
– volume: 13
  start-page: 144
  year: 2019
  end-page: 164
  article-title: ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
  publication-title: J Crohns Colitis
  contributor:
    fullname: Maaser, C; Sturm, A; Vavricka, SR; Kucharzik, T; Fiorino, G; Annese, V
– volume: 101
  start-page: 98
  year: 2020
  end-page: 104
  article-title: on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Gender Differences in Inflammatory Bowel Disease
  publication-title: Digestion
  contributor:
    fullname: Greuter, T; Manser, C; Pittet, V; Vavricka, SR; Biedermann, L
– volume: 12
  start-page: 621
  year: 2018
  end-page: 626
  article-title: Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
  publication-title: J Crohns Colitis
  contributor:
    fullname: Feagan, BG; Schwartz, D; Danese, S; Rubin, DT; Lissoos, TW; Xu, J; Lasch, K
– volume: 149
  year: 2015
  article-title: Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Molendijk, I; Bonsing, BA; Roelofs, H; Peeters, KC; Wasser, MN; Dijkstra, G
– volume: 6
  start-page: 276
  year: 2012
  end-page: 280
  article-title: Genital fistulas in female Crohn’s disease patients.: clinical characteristics and response to therapy
  publication-title: J Crohns Colitis
  contributor:
    fullname: de la Poza, G; López-Sanroman, A; Taxonera, C; Marín-Jimenez, I; Gisbert, JP; Bermejo, F
– volume: 56
  start-page: 53
  year: 2021
  end-page: 58
  article-title: Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature
  publication-title: Scand J Gastroenterol
  contributor:
    fullname: Attauabi, M; Burisch, J; Seidelin, JB
– year: 2018
  article-title: Stem Cell Therapy in Refractory Perineal Crohn’s Disease: Long-term Follow-up
  publication-title: Colorectal Dis
  contributor:
    fullname: Wainstein, C; Quera, R; Fluxá, D; Kronberg, U; Conejero, A; López-Köstner, F
– volume: 6
  start-page: 771
  year: 2012
  end-page: 776
  article-title: Maternal imprinting and female predominance in familial Crohn’s disease
  publication-title: J Crohns Colitis
  contributor:
    fullname: Zelinkova, Z; Stokkers, PC; van der Linde, K; Kuipers, EJ; Peppelenbosch, MP; van der Woude, CP
– volume: 24
  start-page: 4821
  year: 2018
  end-page: 4834
  article-title: Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review
  publication-title: World J Gastroenterol
  contributor:
    fullname: Panes, J; Reinisch, W; Rupniewska, E; Khan, S; Forns, J; Khalid, JM
– volume: 342
  start-page: 173
  year: 1993
  end-page: 174
  article-title: Tumour-necrosis-factor antibody treatment in Crohn’s disease
  publication-title: Lancet
  contributor:
    fullname: Derkx, B; Taminiau, J; Radema, S; Stronkhorst, A; Wortel, C; Tytgat, G; van Deventer, S
– volume: 10
  start-page: 141
  year: 2016
  end-page: 148
  article-title: Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial
  publication-title: J Crohns Colitis
  contributor:
    fullname: Senéjoux, A; Siproudhis, L; Abramowitz, L; Munoz-Bongrand, N; Desseaux, K; Bouguen, G
– volume: 157
  year: 2019
  article-title: Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Löwenberg, M; Vermeire, S; Mostafavi, N; Hoentjen, F; Franchimont, D; Bossuyt, P
– volume: 153
  year: 2017
  article-title: Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Dietz, AB; Dozois, EJ; Fletcher, JG; Butler, GW; Radel, D; Lightner, AL
– volume: 104
  start-page: 371
  year: 2009
  end-page: 383
  article-title: Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease
  publication-title: Am J Gastroenterol
  contributor:
    fullname: Romberg-Camps, MJ; Dagnelie, PC; Kester, AD; Hesselink-van de Kruijs, MA; Cilissen, M; Engels, LG
– volume: 12
  start-page: 930
  year: 2018
  end-page: 938
  article-title: Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials
  publication-title: J Crohns Colitis
  contributor:
    fullname: Panaccione, R; Sandborn, WJ; D’Haens, G; Wolf, DC; Berg, S; Maa, JF
– volume: 14
  start-page: 4
  year: 2020
  end-page: 22
  article-title: ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
  publication-title: J Crohns Colitis
  contributor:
    fullname: Torres, J; Bonovas, S; Doherty, G; Kucharzik, T; Gisbert, JP; Raine, T
– volume: 138
  start-page: 2275
  year: 2010
  end-page: 2281
  article-title: Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease
  publication-title: Gastroenterology
  contributor:
    fullname: Grimaud, JC; Munoz-Bongrand, N; Siproudhis, L; Abramowitz, L; Sénéjoux, A; Vitton, V
– volume: 5
  start-page: 592
  year: 2011
  end-page: 597
  article-title: Prediction of disease complication occurrence in Crohn’s disease using phenotype and genotype parameters at diagnosis
  publication-title: J Crohns Colitis
  contributor:
    fullname: Mazor, Y; Maza, I; Kaufman, E; Ben-Horin, S; Karban, A; Chowers, Y; Eliakim, R
– volume: 13
  start-page: 1756284820915043
  year: 2020
  end-page: 1756284820915043
  article-title: Sex-based differences in inflammatory bowel diseases: a review
  publication-title: Therap Adv Gastroenterol
  contributor:
    fullname: Rustgi, SD; Kayal, M; Shah, SC
– volume: 145
  year: 2013
  article-title: Early administration of azathioprine vs conventional management of Crohn’s Disease: a randomized controlled trial
  publication-title: Gastroenterology
  contributor:
    fullname: Cosnes, J; Bourrier, A; Laharie, D; Nahon, S; Bouhnik, Y; Carbonnel, F
– volume: 2019
  start-page: 6132340
  year: 2019
  end-page: 6132340
  article-title: Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula
  publication-title: Stem Cells Int
  contributor:
    fullname: Herreros, MD; Garcia-Olmo, D; Guadalajara, H; Georgiev-Hristov, T; Brandariz, L; Garcia-Arranz, M
– volume: 13
  start-page: 139
  year: 2019
  end-page: 178
  article-title: Remicade® (infliximab): 20 years of contributions to science and medicine
  publication-title: Biologics
  contributor:
    fullname: Melsheimer, R; Geldhof, A; Apaolaza, I; Schaible, T
– volume: 16
  start-page: 366
  year: 2015
  end-page: 366
  article-title: Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
  publication-title: Trials
  contributor:
    fullname: de Groof, EJ; Buskens, CJ; Ponsioen, CY; Dijkgraaf, MG; D’Haens, GR; Srivastava, N
– volume: 43
  start-page: 946
  year: 2011
  end-page: 952
  article-title: Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn’s disease
  publication-title: Dig Liver Dis
  contributor:
    fullname: Clerici, M; Cassinotti, A; Onida, F; Trabattoni, D; Annaloro, C; Della Volpe, A
– volume: 33
  start-page: 185
  year: 2011
  end-page: 193
  article-title: Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study
  publication-title: Aliment Pharmacol Ther
  contributor:
    fullname: Schreiber, S; Lawrance, IC; Thomsen, OØ; Hanauer, SB; Bloomfield, R; Sandborn, WJ
– volume: 18
  start-page: 1
  year: 2012
  end-page: 9
  article-title: Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn’s disease: results from CARE
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Löfberg, R; Louis, EV; Reinisch, W; Robinson, AM; Kron, M; Camez, A; Pollack, PF
– volume: 70
  start-page: 124
  year: 1981
  end-page: 135
  article-title: Long-term prognosis of inflammatory bowel disease
  publication-title: Postgrad Med
  contributor:
    fullname: Farmer, RG
– volume: 14
  start-page: 155
  year: 2020
  end-page: 168
  article-title: ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
  publication-title: J Crohns Colitis
  contributor:
    fullname: Adamina, M; Bonovas, S; Raine, T; Spinelli, A; Warusavitarne, J; Armuzzi, A
– volume: 388
  start-page: 1281
  year: 2016
  end-page: 1290
  article-title: Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial
  publication-title: Lancet
  contributor:
    fullname: Panés, J; García-Olmo, D; Van Assche, G; Colombel, JF; Reinisch, W; Baumgart, DC
– volume: 22
  start-page: 279
  year: 2013
  end-page: 285
  article-title: Autologous adipose tissue-derived stem cells for the treatment of Crohn’s fistula: a phase I clinical study
  publication-title: Cell Transplant
  contributor:
    fullname: Cho, YB; Lee, WY; Park, KJ; Kim, M; Yoo, HW; Yu, CS
– volume: 28
  start-page: 313
  year: 2013
  end-page: 323
  article-title: Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
  publication-title: Int J Colorectal Dis
  contributor:
    fullname: de la Portilla, F; Alba, F; García-Olmo, D; Herrerías, JM; González, FX; Galindo, A
– volume: 51
  start-page: 90
  year: 2014
  end-page: 96
  article-title: Gender-related differences in clinical course of crohns disease in an Asian population: a retrospective cohort review
  publication-title: Arq Gastroenterol
  contributor:
    fullname: Law, ST; Li, KK
– volume: 23
  start-page: 135
  year: 2019
  end-page: 141
  article-title: Permacol™ collagen paste for cryptoglandular and Crohn’s anal fistula
  publication-title: Tech Coloproctol
  contributor:
    fullname: Brunner, M; Schneider, I; Günther, K; Grützmann, R; Matzel, KE
– volume: 14
  start-page: 33
  year: 2020
  end-page: 45
  article-title: Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
  publication-title: J Crohns Colitis
  contributor:
    fullname: Biemans, VBC; van der Meulen-de Jong, AE; van der Woude, CJ; Löwenberg, M; Dijkstra, G; Oldenburg, B
– volume: 53
  start-page: 299
  year: 2010
  end-page: 304
  article-title: Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach
  publication-title: Can J Surg
  contributor:
    fullname: Sciaudone, G; Di Stazio, C; Limongelli, P; Guadagni, I; Pellino, G; Riegler, G
– volume: 63
  start-page: 1381
  year: 2014
  end-page: 1392
  article-title: A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
  publication-title: Gut
  contributor:
    fullname: Gecse, KB; Bemelman, W; Kamm, MA; Stoker, J; Khanna, R; Ng, SC
– start-page: 1825
  issue: 386
  year: 2015
  end-page: 1834
  article-title: Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomised controlled trial
  publication-title: Lancet
  contributor:
    fullname: Khanna, R; Bressler, B; Levesque, BG; Zou, G; Stitt, LW; Greenberg, GR
– volume: 160
  start-page: 2496
  year: 2021
  end-page: 2508
  article-title: AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
  publication-title: Gastroenterology
  contributor:
    fullname: Feuerstein, JD; Ho, EY; Shmidt, E; Singh, H; Falck-Ytter, Y; Sultan, S
– volume: 109
  start-page: 129
  year: 1995
  end-page: 135
  article-title: Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
  publication-title: Gastroenterology
  contributor:
    fullname: van Dullemen, HM; van Deventer, SJ; Hommes, DW; Bijl, HA; Jansen, J; Tytgat, GN
SSID ssj0024996
Score 2.344739
Snippet ABSTRACT Background: Fistulizing perianal Crohn’s disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients...
BACKGROUNDFistulizing perianal Crohn's disease poses a treatment challenge, and researchers postulate that this phenotype in young male patients could have a...
SourceID doaj
scielo
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 490
SubjectTerms Crohn’s disease
GASTROENTEROLOGY & HEPATOLOGY
perianal fistula
systematic review
treatment
Title FISTULIZING PERIANAL CROHN’S DISEASE: IS THE PATIENT’S SEX A BURDEN? A SYSTEMATIC REVIEW
URI https://search.proquest.com/docview/2895262671
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032023000400490&lng=en&tlng=en
https://doaj.org/article/cdcc596fc54842c593d8f10e315ed78e
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4lcsBWQkJE4RjuPYCReUbrPdoG6omqy0ICQrccYntEW0vfMavB5PwoyTXS0nLlwi50fKaMZjzyfPfMPYG-NlL7VHWKJ1hgClT6JeUyVX5nMFxrg4FAqvar1cq4-bdHPQ6otywkZ64FFx79zgXJpr7zC0VhKHyZD5WEASpzCYDMLqG6c7MLVj2cMwfsrmSnNBlKFCRdSIiRKfCTLJJKIG7Ad7UaDs_zvOpE3o2-F-s3jA7k-BIi9GAR-yO7B9xO6upqPwx-zrosJo7rz6UtVn_ALhWFEX53x--WlZ__75q-GnVVMWTfmeVw1vlyW_KNqqrNvwrik3vOAn68vTsv6Ao-Zz05Yr_GDOx2yJJ2y9KNv5MppaJUQOHRZxoMwg6aTru9T0ymkDoJ3XA3owZJB6pVQOwhgEZ0MOctC9HjKpPBWiJs7I5Ck72l5t4RnjMQweqJtQB70CQXxlXuQZdEprXB27GRM7pdnvIyOGJSSBerZBz5b0bPd6xtsZOyHl7j8nSuvwAA1tJ0Pbfxl6xl7vTGPRBehco9vC1e01_iBPJQIzE8_Y29FmdvLEa9vsRSJhxLho5eL5_xDpmN0LMymUJr5gRzc_buElxig3_aswHfF6ton_AAF42SI
link.rule.ids 230,315,786,790,870,891,2115,27955,27956
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FISTULIZING+PERIANAL+CROHN%E2%80%99S+DISEASE%3A+IS+THE+PATIENT%E2%80%99S+SEX+A+BURDEN%3F+A+SYSTEMATIC+REVIEW&rft.jtitle=Arquivos+de+gastroenterologia&rft.au=Leticia+ROSEVICS&rft.au=Mariane+Cristina+SAVIO&rft.au=Emilton+LIMA+J%C3%9ANIOR&rft.au=Odery+RAMOS+J%C3%9ANIOR&rft.date=2023-11-01&rft.pub=Instituto+Brasileiro+de+Estudos+e+Pesquisas+de+Gastroenterologia+%28IBEPEGE%29&rft.eissn=1678-4219&rft.volume=60&rft.issue=4&rft.spage=490&rft.epage=524&rft_id=info:doi/10.1590%2Fs0004-2803.230402023-28&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_cdcc596fc54842c593d8f10e315ed78e
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-2803&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-2803&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-2803&client=summon